ArticleBlood2017
Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.
Open access · hybridAbstract read
In one paragraph
Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 32 citations in OpenAlex.
- Epigenetic programming by H3K23ac defines lineage fate of Meg3Nature cell biology · 2026Article
- HLTF cooperates with GATA1 to activate transcriptional programs and chromatin remodeling during erythroid development.Nucleic acids research · 2026Article
- Regulation of Alternative Polyadenylation Events by PABPC1 Affects Erythroid Progenitor Cell Expansion.Genomics, proteomics & bioinformatics · 2025Article
- The oncogene protein kinase PIM1 regulates mammalian erythroblast enucleation.Communications biology · 2025Article
- Restricting glycine uptake with bitopertin improves erythropoiesis in preclinical models of Diamond-Blackfan anemia.Blood red cells & iron · 2025Article
- Lysine succinylation precisely controls normal erythropoiesis.Haematologica · 2025Article
- Unveiling the emerging role of curcumin to alleviate ochratoxin A-induced muscle toxicity in grass carp (Ctenopharyngodon idella): in vitro and in vivo studies.Journal of animal science and biotechnology · 2024Article
- CIP/KIP and INK4 families as hostages of oncogenic signaling.Cell division · 2024Review
- Comprehensive Characterization and Global Transcriptome Analysis of Human Fetal Liver Terminal Erythropoiesis.Genomics, proteomics & bioinformatics · 2023Article
- Centrosome function is critical during terminal erythroid differentiation.The EMBO journal · 2022Article
- Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiency.Blood · 2021Article
- The Hsp70 chaperone system: distinct roles in erythrocyte formation and maintenance.Haematologica · 2021Review
- Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development.Cancers · 2021Review
- Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy.Stem cell research & therapy · 2020Article
- Deubiquitylase USP7 regulates human terminal erythroid differentiation by stabilizing GATA1.Haematologica · 2019Article
- Knockdown of spliceosome U2AF1 significantly inhibits the development of human erythroid cells.Journal of cellular and molecular medicine · 2019Article
- Simultaneous Inhibition of EGFR and HER2 via Afatinib Augments the Radiosensitivity of Nasopharyngeal Carcinoma Cells.Journal of Cancer · 2019Article
- Research advances in erythrocyte regeneration sources and methodsCell regeneration (London, England) · 2018Review
- GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.Expert review of hematology · 2018Review
- Orchestration of late events in erythropoiesis by KLF1/EKLF.Current opinion in hematology · 2017Review
Corrections and comments
- Commented on by
Authors and funding
15 authors at 5 institutions in 2 countries.
Xu HanThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Jieying ZhangThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Yuanliang PengThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Minyuan PengXiangya Hospital, Central South University, Changsha, China.
Xiao ChenThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Huiyong ChenThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Jianhui SongXiangya Hospital, Central South University, Changsha, China.
Xiao HuKey Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China.
Mao YeMolecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.
Jianglin LiMolecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Hunan University, Changsha, China.
Vijay G SankaranBroad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Christopher D HillyerRed Cell Physiology Laboratory, New York Blood Center, New York, NY; and.
Narla MohandasRed Cell Physiology Laboratory, New York Blood Center, New York, NY; and.
Xiuli AnLaboratory of Membrane Biology, New York Blood Center, New York, NY.
Jing LiuThe State Key Laboratory of Medical Genetics & School of Life Sciences, Central South University, Changsha, China.
Central South University · CNNew York Blood Center · USHunan University · CNDana-Farber Cancer Institute · USInstitute of Hematology & Blood Diseases Hospital · CN
Funding
YEAST MEMBRANE CYTOSKELETONP01DK032094 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1987 to 2021
$26.7MRED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR37DK026263 · NIDDK · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI NARLA, MOHANDAS · 1995 to 2017
$4.5MRED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR01DK026263 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1986 to 2007
$1.6MTET3 in Terminal Erythroid DifferentiationR01DK100810 · NIDDK · NEW YORK BLOOD CENTER · PI AN, XIULI · 2014 to 2016
$875kNIDDK NIH HHS R01 DK026263NIDDK NIH HHS R01 DK100810NIDDK NIH HHS R37 DK026263
Abstract
Terminal erythroid differentiation is tightly coordinated with cell-cycle exit, which is regulated by cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors (CDKI), yet their roles in erythropoiesis remain to be fully defined. We show here that p19
Indexed as
Blotting, WesternCells, CulturedCyclin-Dependent Kinase Inhibitor p19ErythropoiesisFetal BloodFlow CytometryFluorescent Antibody TechniqueGATA1 Transcription FactorGene Expression RegulationGene Knockdown TechniquesHumansImmunoprecipitationPolymerase Chain ReactionSignal TransductionCDKN2D protein, humanCyclin-Dependent Kinase Inhibitor p19GATA1 protein, humanGATA1 Transcription Factor
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.